JRJarrett Rosenberg

Jarrett Rosenberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jarrett Rosenberg has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterizing ferrous versus ferric iron in Alzheimer's disease using X-ray fluorescence imaging and XANES spectroscopy

    by Dean Tran, Marios Georgiadis, Philip DiGiacomo, Jeff Nirschl, Inma Cobos, Jarrett Rosenberg, Nicholas Edwards, Sharon Bone, Samuel Webb, Michael Zeineh

    Background: The accumulation of iron, such as ferrous Fe 2+ , in the Alzheimer's disease (AD) brain may contribute to neurodegeneration by driving oxidative stress. While elevated iron in AD has been shown, the oxidation state of iron and its regional distribution in AD, particularly in the hippocampus, is unclear. Objective: To characterize the oxidation state and spatial distribution of iron in the hippocampus of AD and control brains, and to assess the effect of tissue thawing on ferrous iron measurements. Methods: We utilized X-ray fluorescence imaging and X-ray absorption near edge structure spectroscopy to localize and analyze iron deposition in fresh-frozen human hippocampal specimens stratified by AD disease stage. To assess the effect of thawing on iron oxidation, we used a cryo-chamber to keep three specimens frozen while their respective deposits were being scanned. These specimens were then allowed to thaw and their same deposits were rescanned for comparison. Results: Compared to control brains, AD specimens exhibited elevated levels of ferrous iron (Fe 2 + ) in the cornu ammonis 1 (CA1)-subiculum subfields—regions known to degenerate early in AD. We also measured a decrease in Fe 2+ levels in AD and control specimens scanned after being thawed. Conclusions: Our findings support the association between elevated Fe 2+ and AD, consistent with existing hypotheses linking redox-active iron to oxidative stress and neuroinflammation. The observed reduction in Fe 2+ levels following thawing suggests that studies using thawed brain samples may underestimate Fe 2+ levels.


  • Improved Strength Prediction Combining MRI Biomarkers of Muscle Quantity and Quality

    by Valentina Mazzoli, Yael Vainberg, Mary E. Hall, Marco Barbieri, Jessica Asay, Julie Muccini, Jarret Rosenberg, Feliks Kogan, Scott Delp, Garry E. Gold

    Muscle strength declines with aging at a faster rate compared with muscle mass, suggesting that not only muscle quantity but also muscle quality and architecture are age‐dependent. This study tested the hypothesis that quantitative MRI (qMRI)‐derived biomarkers of muscle quality (fractional anisotropy [FA], radial diffusivity [RD], axial diffusivity [AD], fat fraction [FF], and T2 relaxation time) and architecture (fascicle length) could improve the prediction of skeletal muscle strength over muscle mass alone. We recruited 24 adults (12 female, age range 30–79 years). Muscle mass was estimated as the volume and cross‐sectional area (CSA) of the quadriceps. FA, RD, and AD parameters, together with fascicle length for the rectus femoris (RF) and vastus lateralis (VL), were derived from diffusion tensor imaging (DTI), and muscle‐T2 was calculated from a multi‐echo spin echo sequence. FF was determined using the Dixon approach. CSA values were combined with FF to calculate the lean CSA. Isometric, eccentric, and concentric knee extension torques were measured for the left and right leg using an isokinetic dynamometer. The univariable assessment of torque was performed using a linear regression. The statistical significance of adding qMRI parameters to the torque prediction models was tested using a mixed‐effect regression. The best univariable predictor of isometric, eccentric, and concentric torque was lean CSA. Adding FA, RF fascicle length, and VL fascicle length to the model improved the prediction of concentric torque compared with CSA alone. The addition of FA, T2, RD, RF fascicle length, and VL fascicle length improved the prediction of eccentric torque over CSA alone. The addition of FF was not significant within the model. Our results confirmed the hypothesis that the inclusion of qMRI parameters of muscle composition and architecture leads to higher R2 coefficients for the prediction of muscle strength compared with models solely based on muscle quantity. These observations support the utility of qMRI for future research on sarcopenia prediction and management.


  • Context-Aware Transformer GAN for Direct Generation of Attenuation and Scatter Corrected PET Data

    by Mojtaba Jafaritadi, Emily Anaya, Garry Chinn, Jarrett Rosenberg, Tie Liang, Craig S. Levin

    We present a context-aware generative deep learning framework to produce photon attenuation and scatter corrected (ASC) PET images directly from non-attenuation and non-scatter corrected (NASC) images. We trained conditional generative adversarial networks (cGAN) on either single-modality (NASC) or multi-modality (NASC+MRI) input data to map NASC images to pixel-wise continuously valued ASC PET images. We designed and evaluated four cGAN models including Pix2Pix, attention-guided cGAN (AG-Pix2Pix), vision transformer cGAN (ViT-GAN), and shifted window transformer cGAN (Swin-GAN). Retrospective 18F-fluorodeoxyglucose (18F-FDG) full-body PET images from 33 subjects were collected and analyzed. Notably, as a particular strength of this work, each patient in the study underwent both a PET/CT scan and a multisequence PET/MRI scan on the same day giving us a gold standard from the former as we investigate ASC for the latter. Quantitative analysis, evaluating image quality using peak signal-to-noise ratio (PSNR), multi-scale structural similarity index (MS-SSIM), normalized mean squared error (NRMSE), and mean absolute error (MAE) metrics, showed no significant impact of input type on PSNR (p=0.95), MS-SSIM (p=0.083), NRMSE (p=0.72), or MAE (p=0.70). For multi-modal input data, Swin-GAN outperformed Pix2Pix (p=0.023) and AG-Pix2Pix (p<0.001), but not ViT-GAN (p=0.154) in PSNR. Swin-GAN achieved significantly higher MS-SSIM than ViT-GAN (p=0.007) and AG-Pix2Pix (p=0.002). Multi-modal Swin-GAN demonstrated reduced NRMSE and MAE compared to ViT-GAN (p=0.023 and 0.031, respectively) and AG-Pix2Pix (both p<0.001), with marginal improvement over Pix2Pix (p<0.064). The cGAN models, in particular Swin-GAN, consistently generated reliable and accurate ASC PET images, whether using multi-modal or single-modal input data. The findings indicate this methodology can be used to generate ASC data from standalone PET scanners or integrated PET/MRI systems, without relying on transmission scan-based attenuation maps.


  • 18F-FSPG PET/CT Imaging of System xC– Transporter Activity in Patients with Primary and Metastatic Brain Tumors

    by Mirwais Wardak, Ida Sonni, Audrey P. Fan, Ryogo Minamimoto, Mehran Jamali, Negin Hatami, Greg Zaharchuk, Nancy Fischbein, Seema Nagpal, Gordon Li, et al.

    PET/CT with (4S)-4-(3-[18F]fluoropropyl)-l-glutamate had high sensitivity for detecting primary brain cancers and brain metastases and could help predict primary brain tumor outcomes using informat... Background The PET tracer (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (18F-FSPG) targets the system xC– cotransporter, which is overexpressed in various tumors. Purpose To assess the role of 18F-FSPG ...


  • Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study

    by Michael Iv, Nathan N. Ng, Sid Nair, Yi Zhang, Jonathan Lavezo, Samuel H. Cheshier, Samantha J. Holdsworth, Michael E. Moseley, Jarrett Rosenberg, Gerald A. Grant, et al.

    No signal differences were found in the brains of children and young adults with arteriovenous malformations following single and multiple ferumoxytol administrations to suggest brain iron retention. Background Iron oxide nanoparticles are an alternative contrast agent for MRI. Gadolinium deposition has raised safety concerns, but it is unknown whether ferumoxytol administration also deposits i...


  • Open Access

    Quantification of brain oxygen extraction and metabolism with [15O]-gas PET: A technical review in the era of PET/MRI

    by Audrey P. Fan, Hongyu An, Farshad Moradi, Jarrett Rosenberg, Yosuke Ishii, Tadashi Nariai, Hidehiko Okazawa, Greg Zaharchuk


  • Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI

    by Ashok J. Theruvath, Florian Siedek, Anne M. Muehe, Jordi Garcia-Diaz, Julian Kirchner, Ole Martin, Michael P. Link, Sheri Spunt, Allison Pribnow, Jarrett Rosenberg, et al.

    Our data showed significant agreement between response assessments at whole-body diffusion-weighted MRI and fluorine 18 fluorodeoxyglucose PET/MRI after induction chemotherapy; the agreement after ... Background Whole-body diffusion-weighted (DW) MRI can help detect cancer with high sensitivity. However, the assessment of therapy response often requires information about tumor metabolism, which ...


  • Open Access

    Histologic evaluation of activation of acute inflammatory response in a mouse model following ultrasound-mediated blood-brain barrier using different acoustic pressures and microbubble doses

    by Aurea Pascal, Ningrui Li, Kendra J. Lechtenberg, Jarrett Rosenberg, Raag D. Airan, Michelle L. James, Donna M. Bouley, Kim Butts Pauly

    Rationale: Localized blood-brain barrier (BBB) opening can be achieved with minimal to no tissue damage by applying pulsed focused ultrasound alongside a low microbubble (MB) dose. However, relatively little is known regarding how varying treatment parameters affect the degree of neuroinflammation following BBB opening. The goal of this study was to evaluate the activation of an inflammatory response following BBB opening as a function of applied acoustic pressure using two different microbubble doses.


  • Quantification of Activity Lost to Delivery-System Residual and Decay in Yttrium-90 Radioembolization

    by Nam S. Hoang, Mohamed H. Khalaf, Jarrett K. Rosenberg, John Kwofie, Aaron L. Reposar, David S. Wang, John D. Louie, Daniel Y. Sze


  • Open Access

    DDIS-15. SYNERGISTIC INHIBITION OF GLIOMA CELL PROLIFERATION BY WITHAFERIN A AND TUMOR TREATING FIELDS

    by Edwin Chang, Christoph Pohling, Nooshin Beygui, Chirag B Patel, Jarrett Rosenberg, Dong Ho Ha, Sanjiv S Gambhir

    Glioblastoma (GBM) is the most aggressive and lethal form of primary brain cancer. Standard therapies are non-specific and often of limited effectiveness; thus, efforts are underway to uncover novel, unorthodox therapies against GBM. In previous studies, we investigated Withaferin A, a steroidal lactone from Ayurvedic medicine that inhibits proliferation in cancers including GBM. Another novel approach, tumor treating fields (TTFields), is thought to disrupt mitotic spindle formation and stymie proliferation of actively dividing cells. We hypothesized that combining TTFields with Withaferin A would synergistically inhibit proliferation in glioblastoma. Human glioblastoma cells (GBM2, GBM39, U87-MG) and human breast adenocarcinoma cells (MDA-MB-231) were isolated from primary tumors. The glioma cell lines were genetically engineered to express firefly luciferase. Proliferative potential was assessed either by bioluminescence imaging or cell counting via hemocytometer. TTFields (4 V/cm) significantly inhibited growth of the four cancer cell lines tested (n=3 experiments per time point, 4 measurements per sample, p<0.02 at least; 2-way ANOVA, control vs. treatment). The combination of Withaferin A (10–100 nM) with TTFields significantly inhibited the growth of the glioma cells to a degree beyond that of Withaferin A or TTFields alone. The interaction of the Withaferin A and TTFields on glioma cells was found to be synergistic in nature (p<0.01, n=3 experiments). These findings were validated by both bioluminescence and hemocytometric measurements. The combination of Withaferin A with TTFields represents a novel approach to treat GBM in a manner that is likely better than either treatment alone and that is synergistic.